Your session is about to expire
← Back to Search
MS FIT App for Multiple Sclerosis (MS FIT Trial)
N/A
Recruiting
Led By Riley Bove, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the MS FIT app, which helps MS patients track falls, view health data, and get fall prevention tips. It targets MS patients because they often experience falls that affect their daily lives. The app uses data from health records, wearables, and surveys to monitor falls and provide personalized advice.
Who is the study for?
This trial is for California residents aged 18 or older with Multiple Sclerosis, who can walk with assistance but may use a wheelchair. They should have fallen before or be at risk of falling and must be able to connect to Wi-Fi at home or work. People with cognitive or visual impairments that make it hard to follow the study plan cannot join.
What is being tested?
The study is testing an app called MS FIT designed for MS patients to track falls, see their health data, talk to their care team about fall risks, and get information on preventing falls.
What are the potential side effects?
Since this trial involves using an application rather than medication, there are no direct medical side effects; however, participants may experience frustration or stress if they encounter technical difficulties.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percentage of patient-clinician encounters initially use the tool (Adoption)
Percentage of patient-clinician encounters use the tool during the 12-month visit (Engagement)
Percentage of patients initially use the tool (Adoption)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: MS FIT: Falls Insight TrackExperimental Treatment1 Intervention
Participants in this arm will receive 12 months use of MS FIT mobile tool intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Multiple Sclerosis (MS) include disease-modifying therapies (DMTs) such as interferons, glatiramer acetate, and oral agents like dimethyl fumarate. These treatments work by modulating the immune system to reduce inflammation and prevent immune cells from attacking the myelin sheath, which is crucial for nerve function.
This is important for MS patients as it helps to slow disease progression, reduce relapse rates, and manage symptoms. The MS Falls Insight Track (MS FIT) application complements these treatments by enabling patients to log their symptoms, visualize their health data, communicate with their care team, and access educational materials, thereby enhancing their ability to manage the disease effectively.
Find a Location
Who is running the clinical trial?
National Library of Medicine (NLM)NIH
40 Previous Clinical Trials
107,577 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,850 Total Patients Enrolled
24 Trials studying Multiple Sclerosis
2,435 Patients Enrolled for Multiple Sclerosis
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,172,520 Total Patients Enrolled
9 Trials studying Multiple Sclerosis
1,220 Patients Enrolled for Multiple Sclerosis
Riley Bove, MDPrincipal InvestigatorUniversity of California, San Francisco
6 Previous Clinical Trials
394 Total Patients Enrolled
6 Trials studying Multiple Sclerosis
394 Patients Enrolled for Multiple Sclerosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with MS according to the 2017 criteria.I am 18 years old or older.I am currently on MS therapy or have not received any treatment.I have a risk of falling, as indicated by my MSWS-12 score or a past fall.I have moderate to severe disability but can still transfer from a wheelchair on my own.
Research Study Groups:
This trial has the following groups:- Group 1: MS FIT: Falls Insight Track
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.